Some of the 41 projects accelerated by the CRAASH Barcelona program have led to the creation or consolidation of innovative startups that already provide services or have brought new healthcare technologies to market. Half of them are solutions to help medical professionals in diagnostic or decision-making processes. Others provide solutions for severe ailments, such as lack of vision or paralysis.
Disruptive ideas for innovative technologies
The selected startups in this section have their products on the market yet or ready to enter it.
ABLE designs, develops and commercializes easy-to-use and affordable exoskeletons for people with spinal cord injury that restores the ability to walk naturally and intuitively.
Aniling is committed to bringing advances in the genomics arena to everyday healthcare and disease prevention. They aim to accelerate epigenomics to help make precision medicine a reality.
AtG Therapeutics is a pre-clinical stage biotech (<em>spinoff</em> from Idibell and ICO) that develops new drugs and biomarkers to prevent cancer metabolic adaptation.
They develop electronic glasses that use computer vision and virtual reality to improve the sight of those with low vision, making them more self-sufficient.
Flomics is a biotech operating in the field of genomics, bioinformatics and NGS. They are developing a novel multicancer screening solution (see <em>Colonyzer</em> project).
This UK-based startup develops an Artificial Intelligence platform that could retrieve knowledge from clinical guidelines and journal articles to answer questions asked by clinicians.
This <em>startup</em> has developed a video-based dietetic app that helps people manage their Irritable Bowel Syndrome (IBS).
The startup developes unique and automated machine intelligence tools that reduce the error associated with visual reading of magnetic resonance images (see <em>Copilot.ms</em> project).